Recipient Characteristics

Pediatric Solid Organ Transplantation

Volumn , Issue , 2009, Pages 259-264

  Canter, Charles E ^a   Naftel, David C ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

ABO incompatible heart transplantation; Angiotensin converting enzyme (ACE); Cardiac transplant research database (CTRD) database; Extracorporeal membrane oxygenators (ECMO); Hypoplastic left heart syndrome; Intravenous inotropic or mechanical circulatory support; Panel reactive antibody (PRA) screens

Indexed keywords

EID: 84957956197     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444312720.ch30     Document Type: Chapter

References (31)

1. Boucek MM, Edwards LB, Keck BM, et al. Registry for the International Society for Heart and Lung Transplantation: seventh official pediatric report, 2004. J Heart Lung Transplant 2004;23:933-47.
2. Trulock EP, Edwards LB, Taylor DO, et al. The Registry for the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report. J Heart Lung Transplant 2004;23:804-15.
3. Mudge GH, Goldstein S, Addonizio LJ, et al. Task Force 3: recipient guidelines/prioritization. 24th Bethesda conference on cardiac transplantation. J Am Coll Cardiol 1993;22:21-31.
4. Costanzo MR, Augustine S, Bourge R, et al. Selection and treatment of candidates for heart transplantation. Circulation 1995;92:3593-612.
5. Fricker FJ, Addonizio L, Bernstein D, et al. Heart transplantation in children: indications. Pediatr Transplant 1999;3:333-42.
6. Shaddy RE, Tani LY, Gidding SS, et al. Beta-blocker treatment of dilated cardiomyopathy with congestive heart failure in children: a multi-institutional experience. J Heart Lung Transplant 1999;18:269-74.
7. Bruns LA, Kichuk Chrisant M, Lamour JM, et al. Carvedilol as therapy in pediatric heart failure: an initial multicenter experience. J Pediatr 2001;138:505-11.
8. Pohwani AL, Murali S, Mathier MM, et al. Impact of beta-blocker therapy on functional capacity criteria for heart transplant listing. J Heart Lung Transplant 2003;22:78-86.
9. Streiper M, Karpawich P, Frias P, et al. Initial experience with cardiac resynchronization therapy for ventricular dysfunction in young patients with surgically operated congenital heart disease. Am J Cardiol 2004;94:1352-4.
10. Rhee EK, Singh GK, Huddleston CB, Canter CE. Cardiac resyn-chronization therapy for moderate-to-severe pediatric heart failure: a pilot study (Abstract). Circulation 2004;110(Suppl 3):480.
11. Lipshultz SE, Sleeper LA, Towbin JA, et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 2003;348:1647-55.
12. Nugent AW, Daubeney PEF, Chondros P, et al. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med 2003;348:1639-46.
13. Cetta F, O'Leary P, Seward J, Driscoll D. Idiopathic restrictive cardiomyopathy in childhood: diagnostic features and clinical course. Mayo Clin Proc 1995;70:634-40.
14. Gewillig M, Mertens L, Moerman P, Dumoulin M. Idiopathic restrictive cardiomyopathy in childhood. Eur Heart J 1996;17: 1413-20.
15. Rivenes SM, Kearney DL, Smith EO, Towbin JA, Denfield SW. Sudden death and cardiovascular collapse in children with restrictive cardiomyopathy. Circulation 2000;102:876-82.
16. Chen JM, Davies RR, Mital SR, et al. Trends and outcomes in transplantation for complex congenital heart disease: 1984-2004. Ann Thorac Surg2004;78:1352-61.
17. Lamour JL, Kanter KR, Naftel DC, et al. The effect of age, diagnosis and previous surgery in 488 children and adults who undergo heart transplantation for congenital heart disease (Abstract). J Am Coll Cardiol 2005;45:322A.
18. Tweddell JS, Hoffman GM, Mussatto KA, et al. Improved survival of patients undergoing palliation of hypoplastic left heart syndrome: lessons learned from 115 consecutive patients. Circulation 2002;106(Suppl I):82-9.
19. Pizzaro C, Mroczek T, Malec E, Norwood WI. Right ventricle to pulmonary artery conduit reduces interim mortality after Stage 1 Norwood for hypoplastic left heart syndrome. Ann Thorac Surg 2004;78:1959-64.
20. Kichuk-Chrisant MR, Naftel D, Drummond-Webb J, et al. Fate of infants with hypoplastic left heart syndrome listed for cardiac transplant: a multi-center study (Abstract). Circulation 1999;100(Suppl I):99.
21. Bernstein D, Naftel DT, Hsu DT, et al. Outcome of listing for cardiac transplantation for failed Fontan: a multi-institutional study (Abstract). J Heart Lung Transplant 1999;18:69.
22. Bernstein D, Naftel D, Chin C, et al. Outcome of listing for cardiac transplantation (tx) for failed Fontan: a follow-up multi-institutional study (Abstract). J Heart Lung Transplant 2004;23:S162.
23. Van Meter CH, Heiney DA. Modifications to and implementation of UNOS policy 3.7 (Allocations of thoracic organs). UNOS policy communication. United Network for Organ Sharing, PO Box 13770, Richmond VA, December, 1998.
24. Ibrahim J, Canter CE, Chinnock RE, et al. Linear and somatic growth following pediatric heart transplantation (Abstract). J Heart Lung Transplant 2002;21:63.
25. Kobashigawa JA, Sabad A, Drinkwater D, et al. Pretransplant panel reactive-antibody screens: are they truly a marker for poor outcome after cardiac transplantation? Circulation 1996; 94:II294-7.
26. Thompson JS, Thacker LR II, Takemoto S. The influence of conventional and cross-reactive group HLA matching on cardiac transplant outcome: an analysis from the United Network of Organ Sharing Scientific Registry. Transplantation 2000;69:2178-86.
27. Mehra M, Uber PA, Uber WE, Scott RL, Park MH. Allosensitization in heart transplantation: implications and management strategies. Curr Opin Cardiol 2003;18:153-8.
28. Hawkins JA, Hillman ND, Lambert LM, et al. Immunogenicity of decellularized cryopreserved allografts in pediatric cardiac surgery: comparison with standard cryopreserved allografts. J Thorac Cardiovasc Surg 2002;126:247-53.
29. Mahle WT, Naftel DC, Rusconi P, Edens RE, Shaddy RE. Panel-reactive antibody cross-reactivity and outcomes in the Pediatric Heart Transplant Study Group (Abstract). J Heart Lung Transplant 2004;23:S167.
30. West LJ, Pollock-BarZiv SM, Dipchand AI, et al. ABO-incompatible heart transplantation in infants. N Engl J Med 2001;344:793-800.
31. Fan X, Ang A, Pollock-BarZiv SM, et al. Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation. Nat Med 2004;10:1227-33.